A detailed history of Beaton Management Co. Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Beaton Management Co. Inc. holds 2,968 shares of MDT stock, worth $265,309. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,968
Previous 2,778 6.84%
Holding current value
$265,309
Previous $242,000 3.31%
% of portfolio
0.13%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$78.71 - $87.02 $14,954 - $16,533
190 Added 6.84%
2,968 $234,000
Q1 2024

May 10, 2024

BUY
$82.84 - $88.09 $911 - $968
11 Added 0.4%
2,778 $242,000
Q4 2023

Feb 09, 2024

SELL
$69.43 - $83.43 $2,777 - $3,337
-40 Reduced 1.43%
2,767 $228,000
Q3 2023

Nov 03, 2023

BUY
$78.22 - $90.4 $1,329 - $1,536
17 Added 0.61%
2,807 $220,000
Q1 2023

May 12, 2023

SELL
$76.72 - $87.58 $6,674 - $7,619
-87 Reduced 3.02%
2,790 $225,000
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $22,854 - $26,322
-300 Reduced 9.44%
2,877 $224,000
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $16,150 - $19,062
200 Added 6.72%
3,177 $257,000
Q1 2022

May 13, 2022

SELL
$100.58 - $112.38 $20,116 - $22,476
-200 Reduced 6.3%
2,977 $330,000
Q3 2020

Nov 13, 2020

SELL
$90.13 - $108.78 $9,013 - $10,878
-100 Reduced 3.05%
3,177 $330,000
Q2 2020

Aug 14, 2020

BUY
$84.11 - $103.33 $8,411 - $10,333
100 Added 3.15%
3,277 $301,000
Q1 2020

May 15, 2020

BUY
$72.92 - $121.3 $7,292 - $12,130
100 Added 3.25%
3,177 $287,000
Q4 2019

Feb 07, 2020

BUY
$104.49 - $114.54 $20,898 - $22,908
200 Added 6.95%
3,077 $349,000
Q3 2019

Nov 15, 2019

BUY
$98.02 - $111.18 $56,361 - $63,928
575 Added 24.98%
2,877 $312,000
Q2 2019

Aug 15, 2019

BUY
$84.15 - $99.38 $193,713 - $228,772
2,302 New
2,302 $224,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Beaton Management Co. Inc. Portfolio

Follow Beaton Management Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beaton Management Co. Inc. with notifications on news.